3,5-二硝基-邻-甲酚 | 497-56-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 3,5-二硝基-邻-甲酚
• 英文名称: 3,5-Dinitro-o-cresol
• 英文别名: 2-methyl-3,5-dinitrophenol
• CAS: 497-56-3
• 化学式: C7H6N2O5
• 分子量: 198.13
• InChiKey: KSHJAFFDLKPUMT-UHFFFAOYSA-N

物化性质

• 熔点：
  85°C
• 沸点：
  335.43°C (rough estimate)
• 密度：
  1.5928 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  112
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3,5-二硝基-邻-甲酚 以91%的产率得到
  参考文献：
  名称：

  SEGURA, P.;BUNNETT, J. F.;VILLANOVA, L., J. ORG. CHEM., 1985, 50, N 7, 1041-1045

  摘要：

  DOI：

文献信息

• Methods and compositions for determining the sequence of nucleic acid molecules
  申请人：QIAGEN Genomics, Inc.

  公开号：US20040115694A1

  公开（公告）日：2004-06-17

  Methods and compounds, including compositions therefrom, are provided for determining the sequence of nucleic acid molecules. The methods permit the determination of multiple nucleic acid sequences simultaneously. The compounds are used as tags to generate tagged nucleic acid fragments which are complementary to a selected target nucleic acid molecule. Each tag is correlative with a particular nucleotide and, in a preferred embodiment, is detectable by mass spectrometry. Following separation of the tagged fragments by sequential length, the tags are cleaved from the tagged fragments. In a preferred embodiment, the tags are detected by mass spectrometry and the sequence of the nucleic acid molecule is determined therefrom. The individual steps of the methods can be used in automated format, e.g., by the incorporation into systems.

  提供了用于确定核酸分子序列的方法和化合物，包括从中制备的组合物。该方法允许同时确定多个核酸序列。这些化合物被用作标记，以生成与所选目标核酸分子互补的带标记的核酸片段。每个标记与特定的核苷酸相关，在优选实施例中，可以通过质谱法检测到。在通过顺序长度分离带标记的片段后，将从带标记的片段中切除标记。在优选实施例中，通过质谱法检测标记，并从中确定核酸分子的序列。该方法的各个步骤可以以自动化格式使用，例如通过纳入系统中。
• METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID MOLECULES UTILIZING SIZING TECHNIQUES
  申请人：Van Ness Jeffrey

  公开号：US20060057566A1

  公开（公告）日：2006-03-16

  Tags and linkers specifically designed for a wide variety of nucleic acid reactions are disclosed, which are suitable for a wide variety of nucleic acid reactions wherein separation of nucleic acid molecules based upon size is required.

  本发明揭示了专门设计用于各种核酸反应的标签和连接剂，适用于需要基于大小分离核酸分子的各种核酸反应。
• Amine Based Additive Composition for Control and Inhibition of Polymerization of Styrene, and Method of Use Thereof
  申请人：Dorf Ketal Chemicals (india) Private Limited

  公开号：US20140316172A1

  公开（公告）日：2014-10-23

  The present invention relates to amine based additive composition for controlling and inhibition of polymerization of aromatic vinyl monomers including styrene comprising (a) one or more of nitroxide (i.e. nitroxyl) compounds; and (b) one or more of aromatic nitro compounds, characterized in that the said composition further comprises one or more of (c) amines, wherein said amine is selected from a group comprising (i) hydroxyl alkyl tertiary amines, (ii) tertiary alkyl amines, (iii) hydroxyl alkyl primary amine; and (iv) mixture thereof. In one embodiment, the present invention also relates to method of using presently provided composition. In another embodiment, the present invention also relates to method of controlling and inhibiting polymerization of aromatic vinyl monomers including styrene by employing presently provided composition. In still another embodiment, the present invention also relates to method of preparation of presently provided composition.

  本发明涉及一种胺基添加剂组合物，用于控制和抑制芳香族乙烯单体的聚合，包括苯乙烯，其中所述组合物包括(a)一种或多种亚硝基（即亚氮基）化合物；和(b)一种或多种芳香族硝基化合物，其特征在于所述组合物进一步包括一种或多种(c)胺，其中所述胺被选自包括(i)羟基烷基三级胺，(ii)三级烷基胺，(iii)羟基烷基一级胺;和(iv)其混合物的一组中。在一个实施例中，本发明还涉及使用目前提供的组合物的方法。在另一个实施例中，本发明还涉及通过使用目前提供的组合物来控制和抑制芳香族乙烯单体的聚合的方法。在仍另一个实施例中，本发明还涉及目前提供的组合物的制备方法。
• Cancer therapy system
  申请人：THERAPEUTICAL SYSTEMS CORPORATION

  公开号：EP0412211A1

  公开（公告）日：1991-02-13

  A method for effecting oncolysis, regression, and control of malignant neoplasms in humans and other mammals without adverse effects on normal body cells is described. An ATP-availability depressor may be combined with a defined nutritional regimen, a fatty acid blocker, an amino acid blocker, a lactate export blocker, or any combination thereof.

  本文描述了一种在不对正常体细胞产生不利影响的情况下，对人类和其他哺乳动物的恶性肿瘤进行溶解、消退和控制的方法。ATP 利用率抑制剂可与确定的营养方案、脂肪酸阻断剂、氨基酸阻断剂、乳酸输出阻断剂或它们的任何组合结合使用。
• Liquid crystal aligning agent and aligning agent-applied liquid crystal display device
  申请人：JAPAN SYNTHETIC RUBBER CO., LTD.

  公开号：EP0503918A1

  公开（公告）日：1992-09-16

  A liquid crystal aligning agent containing a polymer selected from the group consisting of a polyamic acid having a steroidal skeleton and an imidized product thereof; and a liquid crystal display device to which the liquid crystal aligning agent is applied.

  一种液晶对准剂，含有选自具有甾体骨架的聚酰胺酸及其亚酰胺化产物的聚合物；以及一种涂有该液晶对准剂的液晶显示装置。

表征谱图